Again, the popularity of We Go Bee? FDA Warns of Fake Ozemics
Apr 15, 2025
|
Ozempic (component name Semaglutide) is a diabetes treatment for Novo Nordisk, and an injection with the same ingredient sold as an obesity treatment uses the brand name 'Wigobi'. The maximum maintenance dose of the wegobi is 2.4 mg, which is higher than that of ozepic (1 mg).
According to the FDA, Novo Nordisk notified the FDA on the 3rd that hundreds of fake ozemics in the form of 1 mg injections have entered the U.S. drug supply chain. The FDA confiscated the fake products on the 9th, but considered that some of them were still in circulation and urged people to refrain from using fake injections.
The FDA recommended confirming the lot number (PAR0362) and serial number (eight digits beginning with 51746517) of the Ozempic packaging box. The lot number is genuine, but the serial number is fake.
The FDA and Novo Nordisk are jointly conducting ingredient, quality, and safety checks on seized products, and the investigation is not yet complete. However, it is reported that needles, pen labels, packaging, and product instructions are all fake, and there is a risk of infection because the needle has not been confirmed to be sterilized. Novo Nordisk urged people to purchase Ozempic only at state-licensed pharmacies through prescriptions and make sure to check whether the product is pre-used.
The FDA explained that there have been six reports of side effects related to the lot number, but they do not appear to be directly related to fake products, consistent with gastrointestinal symptoms that may occur when taking semaglutide in general.
Earlier in December 2023, the FDA confirmed that fake ozemics were distributed through regular supply chains in the United States and confiscated thousands of products. The World Health Organization (WHO) also officially warned in June last year that fake Olympics were being distributed in the United States and Europe.
This article was translated by Naver AI translator.
